Alere Settles Investor Claims Over Blood Monitor For $20M
Alere Inc. struck a $20 million deal with its investors to resolve claims that it allegedly lied about its blood-monitoring system and caused share price upheaval ahead of its proposed multibillion-dollar...To view the full article, register now.
Already a subscriber? Click here to view full article